Purchase online company lists of companies

Company Summary

Calypte Biomedical Corporation develops, manufactures and markets urine-based screening and supplemental tests for the detection of antibodies to the Human Immunodeficiency Virus, Type-1 (HIV-1), the putative cause of Acquired Immunodeficiency Syndrome (AIDS). It has obtained United States Food and Drug Administration (FDA) approval for the marketing and sale of urine-based tests for the detection of antibodies to the HIV-1. In clinical trials using the screening and supplemental tests together, the urine HIV antibody testing algorithm detected the presence of HIV antibodies in urine with 99.7% sensitivity in subjects previously identified as HIV-1 infected through blood-based (serum/plasma) screening tests.
Calypte Biomedical Corporation develops in vitro testing products to improve the diagnosis of Human Immunodeficiency Virus (HIV) infection, sexually transmitted diseases and other chronic diseases.

General Information

Key figures


  • Company

    50-99 Employees


  • 2007

    500 000 to 1 million USD


Executive information

  • Anthony J Cataldo

    Chairman of the Board

  • R. G.


  • R. D. B.

    Chief Financial Officer

  • R. V.

    VP Operations

  • A. K.

    Chief Executive Officer, Chief Financial Officer, Director, President

  • C. P.


  • D. N.


  • J. D.

    Chief Financial Officer

  • J. J.


  • J. R.

    Senior Management

  • P. E.


  • R. B.

    Executive Vice President

  • R. G.


  • R. W.

    Chief Science Officer

  • R. V.

    VP Operations

  • K. E.

    Director; Chief Financial Officer; Secretary; Director

  • T. A.

    Independent Director

  • S. H.


You might also like

You might also like:

Our business solutions

  • With Kompass :
  • Global presence in more than 60 countries
  • Detailed and up to date company information
  • Comprehensive and filtered company directory